Go Pro
NASDAQ:CLVR

Clever Leaves (CLVR) Stock Price, News & Analysis

Clever Leaves logo
$0.0001 0.00 (0.00%)
As of 09/24/2026 10:30 AM Eastern

About Clever Leaves Stock (NASDAQ:CLVR)

Advanced

Key Stats

Today's Range
$0.0001
▼
$0.01
50-Day Range
N/A
52-Week Range
$0.00
▼
$0.50
Volume
1,019 shs
Average Volume
2,969 shs
Market Capitalization
$175.50
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Clever Leaves Holdings Inc. was a cannabis company focused on the cultivation, processing and distribution of pharmaceutical-grade cannabinoids. The company developed cannabis-based products and cannabinoid extracts for medical, pharmaceutical and wellness applications, with an emphasis on regulated international markets.

Clever Leaves operated cultivation and processing facilities in Colombia and Portugal and pursued distribution opportunities in Europe and other jurisdictions where medical cannabis was permitted. Its activities included the production of cannabis flower, extracts and cannabinoid ingredients intended for use by pharmaceutical companies, medical cannabis providers and other commercial partners.

The company was founded in 2016 and became publicly traded on Nasdaq in 2020 following a business combination with Schultze Special Purpose Acquisition Corp. Kyle Detwiler served as a co-founder and chief executive officer during the company’s public-market period. Clever Leaves later experienced significant financial and operational difficulties and began winding down its business.

AI Generated. May Contain Errors.

Receive CLVR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Clever Leaves and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CLVR Stock News Headlines

Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.tc pixel
Clever Leaves Holdings Inc.
See More Headlines

CLVR Stock Analysis - Frequently Asked Questions

Clever Leaves' stock was trading at $0.0002 on January 1st, 2026. Since then, CLVR shares have decreased by 50.0% and is now trading at $0.0001.

Clever Leaves shares reverse split on Friday, August 25th 2023.The 1-30 reverse split was announced on Thursday, August 24th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, August 24th 2023. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Shares of CLVR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Clever Leaves investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), CrowdStrike (CRWD), Adobe (ADBE), Advanced Micro Devices (AMD) and Salesforce (CRM).

Company Calendar

Today
9/25/2026
Next Earnings (Estimated)
11/13/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:CLVR
CIK
1819615
Fax
N/A
Employees
560
Year Founded
2016

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$17.42 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$14.02 per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
1,755,000
Free Float
1,611,000
Market Cap
$175.50
Optionable
No Data
Beta
3,853.65

Social Links

10 Best Stocks to Own - Fall 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Fall 2026, despite the economic uncertainty rattling markets right now. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:CLVR) was last updated on 9/25/2026 by MarketBeat.com Staff.
From Our Partners